171 related articles for article (PubMed ID: 3029064)
1. Inhibition of gastric H+,K+-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole.
Wallmark B; Briving C; Fryklund J; Munson K; Jackson R; Mendlein J; Rabon E; Sachs G
J Biol Chem; 1987 Feb; 262(5):2077-84. PubMed ID: 3029064
[TBL] [Abstract][Full Text] [Related]
2. Interaction of a K(+)-competitive inhibitor, a substituted imidazo[1,2a] pyridine, with the phospho- and dephosphoenzyme forms of H+, K(+)-ATPase.
Mendlein J; Sachs G
J Biol Chem; 1990 Mar; 265(9):5030-6. PubMed ID: 2156860
[TBL] [Abstract][Full Text] [Related]
3. SCH 28080 is a lumenally acting, K+-site inhibitor of the gastric (H+ + K+)-ATPase.
Keeling DJ; Laing SM; Senn-Bilfinger J
Biochem Pharmacol; 1988 Jun; 37(11):2231-6. PubMed ID: 2837231
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of action of the gastric microsomal (H+ + K+)-ATPase inhibitors SCH 32651 and SCH 28080.
Scott CK; Sundell E; Castrovilly L
Biochem Pharmacol; 1987 Jan; 36(1):97-104. PubMed ID: 3026407
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gastric H+/K+-ATPase by substituted imidazo[1,2-a]pyridines.
Briving C; Andersson BM; Nordberg P; Wallmark B
Biochim Biophys Acta; 1988 Dec; 946(2):185-92. PubMed ID: 2850003
[TBL] [Abstract][Full Text] [Related]
6. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
[TBL] [Abstract][Full Text] [Related]
7. The binding of a K+ competitive ligand, 2-methyl,8-(phenylmethoxy)imidazo(1,2-a)pyridine 3-acetonitrile, to the gastric (H+ + K+)-ATPase.
Keeling DJ; Taylor AG; Schudt C
J Biol Chem; 1989 Apr; 264(10):5545-51. PubMed ID: 2538422
[TBL] [Abstract][Full Text] [Related]
8. Specific labelling of gastric H+,K+-ATPase by omeprazole.
Fryklund J; Gedda K; Wallmark B
Biochem Pharmacol; 1988 Jul; 37(13):2543-9. PubMed ID: 2839196
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of H+/K(+)-ATPase by inorganic phosphate. The role of K+ and SCH 28080.
Van der Hijden HT; Koster HP; Swarts HG; De Pont JJ
Biochim Biophys Acta; 1991 Jan; 1061(2):141-8. PubMed ID: 1847826
[TBL] [Abstract][Full Text] [Related]
10. SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase.
Keeling DJ; Malcolm RC; Laing SM; Ife RJ; Leach CA
Biochem Pharmacol; 1991 Jun; 42(1):123-30. PubMed ID: 1648919
[TBL] [Abstract][Full Text] [Related]
11. Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands.
Fryklund J; Gedda K; Scott D; Sachs G; Wallmark B
Am J Physiol; 1990 May; 258(5 Pt 1):G719-27. PubMed ID: 2159239
[TBL] [Abstract][Full Text] [Related]
12. [Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
Tomoi M; Itoh H; Ueda S; Ono T; Shibayama F
Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):105-11. PubMed ID: 2852155
[TBL] [Abstract][Full Text] [Related]
13. Interaction of fluorescein isothiocyanate with the (H+ + K+)-ATPase.
Jackson RJ; Mendlein J; Sachs G
Biochim Biophys Acta; 1983 May; 731(1):9-15. PubMed ID: 6303415
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
15. Sulfide and sulfoxide derivatives of substituted benzimidazoles inhibit acid formation in isolated gastric glands by different mechanisms.
Fryklund J; Wallmark B
J Pharmacol Exp Ther; 1986 Jan; 236(1):248-53. PubMed ID: 3001289
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of HOE 731 in isolated rabbit gastric glands.
Herling AW; Becht M; Lang HJ; Scheunemann KH; Weidmann K; Scholl T; Rippel R
Biochem Pharmacol; 1990 Oct; 40(8):1809-14. PubMed ID: 2173590
[TBL] [Abstract][Full Text] [Related]
17. Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN- on gastric acid secretion.
Wallmark B; Jaresten BM; Larsson H; Ryberg B; Brändström A; Fellenius E
Am J Physiol; 1983 Jul; 245(1):G64-71. PubMed ID: 6307064
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of gastric proton pump inhibition by calcium channel antagonists.
Nandi J; King RL; Kaplan DS; Levine RA
J Pharmacol Exp Ther; 1990 Mar; 252(3):1102-7. PubMed ID: 2156990
[TBL] [Abstract][Full Text] [Related]
19. The relationship between gastric acid secretion and gastric H+,K+-ATPase activity.
Wallmark B; Larsson H; Humble L
J Biol Chem; 1985 Nov; 260(25):13681-4. PubMed ID: 2997178
[TBL] [Abstract][Full Text] [Related]
20. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
